Whitepaper: An Opportunity for Digital Continuity in the Pharmaceutical Industry

opportunity for digital continuity > asset cover > Dassault Systèmes®

PDF 2.55 MB

IDMP compliance requires that the information sent to regulatory agencies be consistent in format and ISO coding. This provides a significant opportunity beyond compliance: digital continuity can provide a competitive advantage to your pharmaceutical organization.

To achieve this, digital continuity requires a platform capable of providing the following:

  • Medicinal Product Structure Management (MPSM), based on IDMP requirements
  • Full specification management
  • End-to-End change control (including impact analysis and involvement of appropriate subject matter experts)
  • Regulatory intelligence capabilities

Download the whitepaper to learn more.